TP53 and neuroendocrine carcinoma: The authors termed these aggressive, rapidly progressing high‐grade NEN as “NEC‐like NETs.” Despite their aggressive behaviour and the prevalence of TP53 alterations, most retained molecular features characteristic of NET, with only one NEC‐like NET acquiring an RB1 alteration during disease progression.